Literature DB >> 18579502

Prognostic value of transthoracic coronary flow reserve in medically treated patients with proximal left anterior descending artery stenosis of intermediate severity.

Patrick Meimoun1, Tahar Benali, Frederic Elmkies, Smain Sayah, Anne Luycx-Bore, Luc Doutrelan, Zemir Hamdane, Jacques Boulanger, Christophe Tribouilloy.   

Abstract

AIMS: Prognostic value of transthoracic coronary flow reserve (T-CFR) is not established in patients with left anterior descending artery (LAD) stenosis of intermediate severity. Objective is to determine the prognosis value of T-CFR>2 in medically treated patients with angiographically intermediate [50-70% QCA (quantitative coronary angiography)] proximal LAD stenosis. METHODS AND
RESULTS: Among 110 consecutive patients with intermediate LAD stenosis who underwent prospectively T-CFR in the distal part of the LAD after intravenous administration of adenosine to assess the functional significance of the stenosis, 80 patients had T-CFR>2 and were treated medically without revascularization (Group 1). Among the 30 patients who had T-CFR<2, an additional dobutamine stress echocardiography (DSE) was performed: 15 had a negative DSE; were treated medically and served as a comparative group (Group 2), and 15 had a positive DSE; underwent LAD revascularization, and were excluded from further analysis. All patients completed follow-up (16+/-10 months). During the follow-up period (range 6-45 months), 76 patients (95%) remained free of death or LAD-related event in Group 1, vs. 12 patients (80%) in Group 2. By Kaplan-Meier method, at 30 months the per cent estimated survival free from death or target vessel-related events was 92+/-4% in Group 1 and 44+/-22% in Group 2 (P<0.01). By multivariate analysis, T-CFR remained the only independent predictor of death or LAD-related events.
CONCLUSION: In patients with proximal LAD stenosis of intermediate severity and T-CFR>2, deferral of revascularization is associated with low event rate.

Entities:  

Mesh:

Year:  2008        PMID: 18579502     DOI: 10.1093/ejechocard/jen190

Source DB:  PubMed          Journal:  Eur J Echocardiogr        ISSN: 1532-2114


  7 in total

1.  The physiologic evaluation of stenosis by transthoracic Doppler: a bit of theory, a lot of practice.

Authors:  Jonathan R Lindner
Journal:  J Am Soc Echocardiogr       Date:  2011-04       Impact factor: 5.251

2.  Positive effects of aggressive vasodilator treatment of well-treated essential hypertensive patients.

Authors:  M Engholm; M J Mulvany; A Eftekhari; O N Mathiassen; N H Buus; K L Christensen
Journal:  J Hum Hypertens       Date:  2016-03-10       Impact factor: 3.012

3.  Assessment of left anterior descending artery stenosis of intermediate severity by fractional flow reserve, instantaneous wave-free ratio, and non-invasive coronary flow reserve.

Authors:  P Meimoun; J Clerc; D Ardourel; U Djou; S Martis; T Botoro; F Elmkies; H Zemir; A Luycx-Bore; J Boulanger
Journal:  Int J Cardiovasc Imaging       Date:  2016-10-17       Impact factor: 2.357

Review 4.  Coronary Artery Imaging with Transthoracic Doppler Echocardiography.

Authors:  Masaaki Takeuchi; Akemi Nakazono
Journal:  Curr Cardiol Rep       Date:  2016-07       Impact factor: 2.931

5.  Feasibility of 3D4D echocardiography for the detection of colour-coded flow in the left anterior descending artery.

Authors:  Stephan Stoebe; Dietrich Pfeiffer; Andreas Hagendorff
Journal:  Echo Res Pract       Date:  2014-07-23

6.  Comparison of 5-Year Outcomes for Patients With Coronary Artery Disease in Groups With and Without Revascularization With Different Results of Stress Echocardiography.

Authors:  Angela Zagatina; Ludmila Krylova; Yuliya Vareldzhan; Tatyana V Tyurina; Olga Clitsenko; Nadezhda Zhuravskaya
Journal:  Cardiol Res       Date:  2013-10-15

7.  Coronary flow reserve and cardiovascular outcomes: a systematic review and meta-analysis.

Authors:  Mihir A Kelshiker; Henry Seligman; James P Howard; Haseeb Rahman; Michael Foley; Alexandra N Nowbar; Christopher A Rajkumar; Matthew J Shun-Shin; Yousif Ahmad; Sayan Sen; Rasha Al-Lamee; Ricardo Petraco
Journal:  Eur Heart J       Date:  2022-04-19       Impact factor: 35.855

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.